Literature DB >> 18703046

Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction.

Kazuo Yano1, Koh Kawasaki, Tsuyoshi Hattori, Shunsuke Tawara, Yoshinori Toshima, Ichiro Ikegaki, Yasuo Sasaki, Shin-ichi Satoh, Toshio Asano, Minoru Seto.   

Abstract

Evidence that Rho-kinase is involved in cerebral infarction has accumulated. However, it is uncertain whether Rho-kinase is activated in the brain parenchyma in cerebral infarction. To answer this question, we measured Rho-kinase activity in the brain in a rat cerebral infarction model. Sodium laurate was injected into the left internal carotid artery, inducing cerebral infarction in the ipsilateral hemisphere. At 6 h after injection, increase of activating transcription factor 3 (ATF3) and c-Fos was found in the ipsilateral hemisphere, suggesting that neuronal damage occurs. At 0.5, 3, and 6 h after injection of laurate, Rho-kinase activity in extracts of the cerebral hemispheres was measured by an ELISA method. Rho-kinase activity in extracts of the ipsilateral hemisphere was significantly increased compared with that in extracts of the contralateral hemisphere at 3 and 6 h but not 0.5 h after injection of laurate. Next, localization of Rho-kinase activity was evaluated by immunohistochemical analysis in sections of cortex and hippocampus including infarct area 6 h after injection of laurate. Staining for phosphorylation of myosin-binding subunit (phospho-MBS) and myosin light chain (phospho-MLC), substrates of Rho-kinase, was elevated in neuron and blood vessel, respectively, in ipsilateral cerebral sections, compared with those in contralateral cerebral sections. These findings indicate that Rho-kinase is activated in neuronal and vascular cells in a rat cerebral infarction model, and suggest that Rho-kinase could be an important target in the treatment of cerebral infarction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703046     DOI: 10.1016/j.ejphar.2008.07.045

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain.

Authors:  Jianhua Wu; Jianzhe Li; Hankun Hu; Ping Liu; Yunxiang Fang; Dongfang Wu
Journal:  Cell Mol Neurobiol       Date:  2012-05-03       Impact factor: 5.046

2.  Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats.

Authors:  Mutsumi Fujii; Kamil Duris; Orhan Altay; Yoshiteru Soejima; Prativa Sherchan; John H Zhang
Journal:  Neurochem Int       Date:  2011-12-30       Impact factor: 3.921

3.  Fasudil mesylate protects PC12 cells from oxidative stress injury via the Bax-mediated pathway.

Authors:  Qin Li; Dong Liu; Xianju Huang; Lianjun Guo
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

4.  Increased dendrite branching in AbetaPP/PS1 mice and elongation of dendrite arbors by fasudil administration.

Authors:  Brian A Couch; George J DeMarco; Shannon L Gourley; Anthony J Koleske
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke.

Authors:  Xiaoye Mo; Ting Li; Guang Ji; Wei Lu; Zhiping Hu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

6.  Correspondence between neurological deficit, cerebral infarct size, and Rho-kinase activity in a rat cerebral thrombosis model.

Authors:  Koh Kawasaki; Kazuo Yano; Kunie Sasaki; Shunsuke Tawara; Ichiro Ikegaki; Shin-Ichi Satoh; Yuji Ohtsuka; Yuki Yoshino; Hiroshi Kuriyama; Toshio Asano; Minoru Seto
Journal:  J Mol Neurosci       Date:  2009-01-23       Impact factor: 3.444

7.  Cerebral vasospasm pharmacological treatment: an update.

Authors:  Ioannis Siasios; Eftychia Z Kapsalaki; Kostas N Fountas
Journal:  Neurol Res Int       Date:  2013-01-31

8.  Activating transcription factor 3 and the nervous system.

Authors:  David Hunt; Gennadij Raivich; Patrick Norval Anderson
Journal:  Front Mol Neurosci       Date:  2012-02-14       Impact factor: 5.639

9.  Anomalous dispersion analysis of inhibitor flexibility: a case study of the kinase inhibitor H-89.

Authors:  Alexander Pflug; Kenneth A Johnson; Richard A Engh
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-26

10.  The role of Rho/Rho-kinase pathway and the neuroprotective effects of fasudil in chronic cerebral ischemia.

Authors:  Ya-Yun Yan; Xiao-Ming Wang; Yan Jiang; Han Chen; Jin-Ting He; Jing Mang; Yan-Kun Shao; Zhong-Xin Xu
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.